Blood test could replace painful bone marrow biopsy for rare disease
NCT ID NCT07562542
First seen May 02, 2026 · Last updated Jun 19, 2026 · Updated 10 times
Summary
This study is testing whether a blood test can diagnose systemic mastocytosis, a rare disease where too many mast cells build up in the body. Currently, diagnosis requires a painful bone marrow biopsy. Researchers will compare the blood test results to bone marrow samples from 50 adult volunteers to see if the blood test is accurate enough to replace the biopsy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIT-D816V MUTATION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology
RECRUITINGSuzhou, Jiangsu, 215000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could provide a simple blood test to diagnose systemic mastocytosis, avoiding the need for painful bone marrow biopsies.
What could go wrong
This is a small, early-stage observational study. The blood test may not be accurate enough to replace bone marrow biopsy, and results may not apply to all patients.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.